In breast tumor biopsies, CCNE1 overexpression was shown to significantly correlate with resistance to palbociclib74, whereas lower CCNE1 mRNA levels were associated with improved therapeutic response in HR+ breast cancer107,116. This evidence concerns the gene CCNE1 and breast neoplasm.